Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 04/08/2011 Hartmann AG Logo

    HARTMANN stands its ground in an increasingly difficult market

    In the first half of 2011 the HARTMANN GROUP was confronted with an unfavorable market environment. Raw material and logistics costs continued to rise significantly in the overall economic recovery. Furthermore there has been added price pressure from customers due to the national deficits and the associated budget restrictions in the health systems. Nevertheless HARTMANN succeeded in further increasing sales revenues by 6.2 to EUR 845.3 million…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hartmann-stands-its-ground-in-an-increasingly-difficult-market
  • Press release - 23/07/2011

    Innovative strength in Baden-Württemberg

    The Baden-Württemberg Ministry of Finance and Economics presented the results of two studies that evaluated the innovative strength of Baden-Württemberg in comparison to other regions around the world. The studies were carried out by the University of Hohenheim and the independent research institute BAK Basel Economics AG BAK Basel on behalf of the Baden-Württemberg Ministry of Finance and Economics and they were financed by the Baden-Württemberg…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/innovative-strength-in-baden-wuerttemberg
  • Press release - 15/07/2011 10938_de.jpg

    HITS Participates in a new DFG Research Unit on Blood Coagulation

    Scientists from the Heidelberg Institute for Theoretical Studies participate in a new Research Unit on blood coagulation sponsored by the German Research Foundation (DFG). The aim of the DFG funding is to support a successful existing cooperation between scientists over several years.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hits-participates-in-a-new-dfg-research-unit-on-blood-coagulation
  • Article - 20/12/2010 13269_de.jpg

    Michael Reth – Immunobiological discoveries that meet resistance

    Dr Michael Reth professor at the Max Planck Institute of Immunobiology and the University of Freiburg and some of his colleagues have recently uncovered the mechanism that foreign substances use to activate B cells of the immune system. The researchers were using synthetic biology methods long before this particular branch of science existed in its present form. Their results require a paradigm change and a revision of the reference books.

    https://www.gesundheitsindustrie-bw.de/en/article/news/michael-reth-immunobiological-discoveries-that-meet-resistance
  • Guest article - 05/12/2010 Sandra Barudio (centre) talking with two of her Chinese colleagues in the GenePharma library.

    Report from Jiangsu

    Sandra Barudio a chemist from the University of Freiburg is currently doing four months practical training in the company GenePharma based in Suzhou Jiangsu province China. Barudio arrived in China at the beginning of September 2010 funded by a China grant from the Baden-Württemberg Ministry of Science Research and the Arts. She is a doctoral student in her second year at the Institute of Chemistry at Freiburg University and is doing her doctoral…

    https://www.gesundheitsindustrie-bw.de/en/article/news/report-from-jiangsu
  • Press release - 03/12/2010

    Nanjing Medicinal Group

    Nanjing Medicinal group a state-owned enterprise is among the top six pharmaceutical conglomerates in China. It is composed of 15 pharmaceutical companies and controls 1000 retail drugstores. A hospital and a research institute are also part of the group.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanjing-medicinal-group
  • Press release - 16/11/2010 12926_de.jpg

    Nycomed is keeping the pace in third quarter 2010 - US Food & Drug Administration to decide on the approval of Daxas®

    Nycomed’s strategy of focusing on emerging markets and specialty products is paying off. The third quarter results shows that the sales of Key Products and in emerging markets are continuing to help offset the impact from the loss of exclusivity of pantoprazole. Daxas® (roflumilast) has recently been launched in the first EU markets and further launches are underway over the coming months. To accelerate the expansion in China, one of the fastest…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-is-keeping-the-pace-in-third-quarter-2010-us-food-drug-administration-to-decide-on-the-appro
  • Press release - 04/11/2010 10084_de.jpg

    Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma

    Nycomed today announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd. (Techpool), a fast-growing Chinese bio-pharmaceutical company based in Guangdong. Techpool, founded in 1993, specialises in the research, development, manufacturing and marketing of biologic drugs derived from natural sources.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-to-acquire-of-majority-stake-in-guangdong-techpool-bio-pharma
  • Article - 03/10/2010 12509_de.jpg

    LimCo International - innovative methods to assess water pollution

    LimCo International has developed the Multispecies Freshwater Biomonitor a unique continuous early warning system that enables the fully automated detection of water contamination. The companys GamTox toxicity test can be used to assess the ecological situation of flowing waters.

    https://www.gesundheitsindustrie-bw.de/en/article/news/limco-international-innovative-methods-to-assess-water-pollution
  • Press release - 09/09/2010 China medical city logo

    China Medical City, Taizhou

    Taizhou is a commercial and industrial city of around 5 million inhabitants located in the Yantze River Delta about half way between Nanjing and Suzhou. Within the Taizhou city boundaries on a total area of 25 square kilometers China Medical City CMC a national-level pharmaceutical high-tech park is currently under construction.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/china-medical-city-taizhou
  • Press release - 09/09/2010

    Jiangnan University, Wuxi

    Jiangnan University JU is one of Chinas key universities of the 211 Project and functions under the Ministry of Education. The university host the National Engineering Laboratory of Fermentation Technology the Key Laboratory of Industrial Biotechnology the Engineering Research Center of Bioactive Product Processing Jiangsu Province and the Collection of Industrial Microbes Resources.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/jiangnan-university-wuxi
  • Press release - 09/09/2010 Entrance to the new Nanjing R&D Center of C&O Pharmaceuticals

    C&O Pharmaceutical Technology (Holdings) Ltd., Nanjing

    Headquartered in Hong Kong and listed on the Singapore Exchange since October 2005 CO Pharmaceutical Technology Holdings Limited CO is an integrated pharmaceutical group in the Peoples Republic of China. The business model spans the entire value chain in the pharmaceutical industry which includes Reasearch and Development RD manufacturing marketing and distribution of CO branded respectively third party pharmaceutical products.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/c-o-pharmaceutical-technology-holdings-ltd-nanjing
  • Press release - 25/06/2010 08185_de.jpg

    Delegation trip to China – 30 years of scientific relations

    The Baden-Württemberg Minister of Science Professor Dr. Peter Frankenberg and Secretary of State Dr. Dietrich Birk have returned from a delegation trip to the Chinese region of Shanghai. They were accompanied by representatives of Baden-Württemberg universities. Frankenberg and Birk used the trip to highlight the fact that China has been an important long-term partner to many universities in the state of Baden-Württemberg. During their trip the…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/delegation-trip-to-china-30-years-of-scientific-relations
  • Press release - 23/06/2010 two buildings with lines of trees in front

    Technology park „bioBAY“ - life science infrastructure the Chinese way

    Being one of Baden-Württemberg’s global partner regions, the Chinese province of Jiangsu deserves special attention in the field of life sciences. The highly dynamic bioBAY park located in the city of Suzhou puts a strong emphasis on bio- and nanotechnologies. With its numerous science and business opportunities bioBAY has a lot to offer also to potential partners from Baden-Württemberg.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/technology-park-biobay-life-science-infrastructure-the-chinese-way
  • Article - 12/06/2010 11552_de.jpg

    Correcting enzyme defects using stem cells

    Bone marrow transplantation was originally developed for the treatment of leukaemias and other malignant diseases of the haemotopoietic system. Thanks to increasing technological process it has been possible to considerably expand the treatment spectrum over the last few years. Dr. Ingo Müller paediatrician at the University Hospital in Tübingen now uses bone marrow transplantation for the therapy of genetic metabolic diseases with highly…

    https://www.gesundheitsindustrie-bw.de/en/article/news/correcting-enzyme-defects-using-stem-cells
  • Article - 15/04/2010 11188_de.jpg

    Molecular biomechanics or mechanobiochemistry

    Frauke Gräter is head of the Molecular Biomechanics research group at the Institute for Theoretical Studies in Heidelberg. Gräter uses computer-based methods to investigate the mechanical forces acting on biological macromolecules in the nanometre range. Her team was also able to show that highly complex processes such as haemostasis are regulated by shear forces.

    https://www.gesundheitsindustrie-bw.de/en/article/news/molecular-biomechanics-or-mechanobiochemistry
  • Press release - 17/03/2010 European Molecular Biology Laboratory

    Bacterial balance that keeps us healthy

    Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, working within the European project MetaHIT and in collaboration with colleagues at the Beijing Genomics Institute at Shenzhen, China, established a reference gene set for the human gut microbiome – a catalogue of the microbe genes present in the human gut. Their work proves that high-throughput techniques can be used to sequence environmental samples, and…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/bacterial-balance-that-keeps-us-healthy
  • Article - 15/07/2009 The photo shows instruments in a laboratory

    The gap in the value creation chain

    On a national level the University of Freiburg comes out reasonably well in comparison with other universities regarding the number of patents filed and licensed. But is it enough to protect an intellectual property and sell it to a company? No says Prof. Dr. Bernhard Arnolds from the Central Office of Research Funding and Technology Transfer at the University of Freiburg.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-gap-in-the-value-creation-chain
  • Article - 25/08/2008 import_03396_de.jpg

    Markers that reveal the correct biological age

    Researchers at the University of Ulm have just identified a number of proteins that reveal the biological age of a person. These biomarkers might be used in medical applications to adapt the medical treatment of older people to their individual biological age.

    https://www.gesundheitsindustrie-bw.de/en/article/news/markers-that-reveal-the-correct-biological-age
  • Press release - 11/08/2008

    Stockert GmbH - Electrical scalpels made in Freiburg

    How can a doctor reach a brain tumour with a scalpel? Stockert devices which use catheter technology and probes to localise and electrically neutralise problematic tissue help to solve the problem in hospitals all over the world.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/stockert-gmbh-electrical-scalpels-made-in-freiburg
  • Article - 17/06/2008 The world is getting closer and the way is paved for internationalisation (Photo: BioRegio STERN/Czurgel)

    "Study and work abroad!”"

    Quick practically oriented and above all international The new bachelor and masters degrees in the natural sciences have been introduced to bring German university qualifications into line with the requirements of the international job market as well as to facilitate the uncomplicated exchange of scientists across the globe. However not everything always works out as planned. Research abroad is often limited by time and money.

    https://www.gesundheitsindustrie-bw.de/en/article/news/study-and-work-abroad
  • Article - 28/05/2008

    Guido Oelkers joins Nycomed Executive Committee

    Nycomed announced the appointment of Guido Oelkers as the new Executive Vice President Commercial Operations. It is planned that he joins Nycomed in September 2008. Based in Zurich Guido Oelkers will be in charge of all Commercial Operations and its Area Managers with the exception of RussiaCIS.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/guido-oelkers-joins-nycomed-executive-committee
  • Press release - 19/05/2008 import_04227_de.jpg

    Viruses caught red-handed

    Prof. Thilo Stehle biochemist at the University of Tübingen wants to capture and accurately study the moment at which a virus binds to a cell. He is hoping that further insights into this process might some time enable the development of drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/viruses-caught-red-handed
  • Article - 11/05/2008

    Market report on antioxidants published

    In an independent market study by Ceresana Research the latest data facts and trends of the antioxidant market are analysed and presented. Data concerning the antioxidant market are subdivided by region based on value and quantity.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/market-report-on-antioxidants-published
  • Press release - 07/05/2008 Logo ChemCon

    ChemCon – and how an ideal niche was found and occupied

    At first sight the business idea seems somehow strange Who would deliberately choose to develop and produce pharmaceutical substances that are hardly required and if so only in small quantities. Dr. Raphael Vogler and Dr. Peter Gockel the founders and owners of Freiburg-based ChemCon GmbH have done exactly that - and found an ideal niche for their company. Even the largest companies of the industry are benefiting from ChemCons know-how and…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/chemcon-and-how-an-ideal-niche-was-found-and-occupied

Page 3 / 4

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search